Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00323791
Status:
TERMINATED
Last Update Posted:
2009-12-11
First Post:
2006-05-08
Brief Title:
Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
Sponsor:
University of Medicine and Dentistry of New Jersey
Organization:
Rutgers The State University of New Jersey
Organization Data
Organization:
Rutgers The State University of New Jersey
Class:
OTHER
Study ID:
CDR0000539400
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Medicine and Dentistry of New Jersey
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Mark Stein MD
Old Organization:
UMDNJCINJ
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |